Aligos Therapeutics, Inc. logo

Aligos Therapeutics, Inc.

1799448

Aligos Therapeutics is a clinical-stage biotechnology company headquartered in South San Francisco, California. They are focused on developing best-in-class therapies for liver and viral diseases, specifically targeting areas with high unmet medical needs. Their pipeline includes treatments for chronic HBV infection and MASH. Aligos aims to significantly improve patient outcomes through science-driven approaches and a patient-centric focus.

86
Altamente Confiable
Puntuación de Confianza

Registro Oficial

Nombre Legal
Aligos Therapeutics, Inc.
Número de organización
1799448
Número de IVA
000000000
Estado de la Empresa
Active
Dirección
ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO, CA 94080
Códigos de Industria
Biological Products, (No Diagnostic Substances), 2836

Análisis de Calidad IA

Industria
Biotechnology
SSL/HTTPS
Seguro
Correo profesional
Correo de contacto
info@aligos.com

🌟 Empresas similares de confianza

Metagenomi, Inc.

Metagenomi, Inc. logo
74/100 · Confiable

Metagenomi is an in vivo genome editing company creating curative genetic medicines using proprietary technologies. They leverage metagenomics to discover editing tools potentially capable of correcting any type of genetic mutation. The company focuses on diseases with well-understood biology and clear regulatory pathways, and intends to expand their pipeline through genetic editing capabilities.

5959 HORTON STREET, Estados Unidos
Ver perfil

ARCTICZYMES TECHNOLOGIES ASA

ARCTICZYMES TECHNOLOGIES ASA logo
80/100 · Altamente Confiable

ArcticZymes Technologies es una empresa de biotecnología especializada en el desarrollo y la producción de enzimas. Ofrece nucleasas para la biofabricación y el diagnóstico molecular, incluyendo las Nucleasas Activas en Sal (SAN). La empresa es conocida por sus polimerasas y enzimas utilizadas en aplicaciones de investigación e industriales.

Sykehusvegen 23, Noruega
Ver perfil

ACD PHARMACEUTICALS AS

ACD PHARMACEUTICALS AS logo
80/100 · Altamente Confiable

ACD Pharma is a Norwegian R&D company developing biocontrol products based on bacteriophages, focusing on combating harmful bacteria in animals and humans. They launched Custus®YRS, the world's first bacteriophage product for aquaculture. They collaborate with pharmaceutical and scientific teams to fight antibiotic resistance, extending their advancements across sectors.

Lofoten Bio Centre, Noruega10 empleados
Ver perfil